Leukemia
Displaying 1 - 13 of 13
Stubbins, R. J., Arnovitz, S., Vagher, J., Asom, A., Perpich, M., Pies, M., Akpan, I. J., Chew, E., Bridgers, J., Karsan, A., Rodgers, C., Koppayi, A., Basdag, H., Drazer, M. W., Das, S., Cheng, J., Osman, A. E. G., & Godley, L. A. (2025). Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variants. Leukemia. https://doi.org/10.1038/s41375-025-02635-1
Publication Date
Columbia Affiliation
Millot, F., Ampatzidou, M., Moulik, N. R., Tewari, S., Elhaddad, A., Hammad, M., Pichler, H., Lion, T., Tragiannidis, A., Shima, H., An, W., Yang, W., Karow, A., Farah, R., Luesink, M., Dworzak, M., Sembill, S., De Moerloose, B., Sedlacek, P., … Suttorp, M. (2025). Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations. Leukemia. https://doi.org/10.1038/s41375-025-02543-4
Publication Date
Columbia Affiliation
View
Goda, C., Kulkarni, R., Bustos, Y., Li, W., Rudich, A., Balcioglu, O., Chidester, S., Urs, A. P., Karunasiri, M., Al-Marrawi, Y., Korn, E., Kanna, S., Garfinkle, E. A. R., Shah, N., Wooten, A., Mundy-Bosse, B., Sehgal, L., Zhang, B., Marcucci, G., … Dorrance, A. M. (2024). Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia. Leukemia, 39(1), 51–63. https://doi.org/10.1038/s41375-024-02415-3
Publication Date
Columbia Affiliation
View
Corinaldesi, C., Holmes, A. B., Martire, G., Tosato, A., Rizzato, D., Lovisa, F., Gallingani, I., Shen, Q., Ferrone, L., Harris, M., Davies, K., Molinaro, L., Mortara, U., Dei Tos, A. P., Ofori, K., D’Amore, E. S. G., Chiarle, R., Ngan, B., Carraro, E., … Basso, K. (2024). Single-cell transcriptomics of pediatric Burkitt lymphoma reveals intra-tumor heterogeneity and markers of therapy resistance. Leukemia, 39(1), 189–198. https://doi.org/10.1038/s41375-024-02431-3
Publication Date
Columbia Affiliation
View
Patel, B., Zhou, Y., Babcock, R. L., Ma, F., Zal, M. A., Kumar, D., Medik, Y. B., Kahn, L. M., Pineda, J. E., Park, E. M., Schneider, S. M., Tang, X., Raso, M. G., Jeter, C. R., Zal, T., Clise-Dwyer, K., Keyomarsi, K., Giancotti, F. G., Colla, S., & Watowich, S. S. (2024). STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response. Leukemia, 38(5), 1143–1155. https://doi.org/10.1038/s41375-024-02218-6
Publication Date
Columbia Affiliation
Boila, L. D., Ghosh, S., Bandyopadhyay, S. K., Jin, L., Murison, A., Zeng, A. G. X., Shaikh, W., Bhowmik, S., Muddineni, S. S. N. A., Biswas, M., Sinha, S., Chatterjee, S. S., Mbong, N., Gan, O. I., Bose, A., Chakraborty, S., Arruda, A., Kennedy, J. A., Mitchell, A., … Sengupta, A. (2023). KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition. Leukemia, 37(4), 751–764. https://doi.org/10.1038/s41375-023-01833-z
Publication Date
Columbia Affiliation
Sembill, S., Ampatzidou, M., Chaudhury, S., Dworzak, M., Kalwak, K., Karow, A., Kiani, A., Krumbholz, M., Luesink, M., Naumann-Bartsch, N., De Moerloose, B., Osborn, M., Schultz, K. R., Sedlacek, P., Giona, F., Zwaan, C. M., Shimada, H., Versluijs, B., Millot, F., … Metzler, M. (2023). Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations. Leukemia, 37(3), 505–517. https://doi.org/10.1038/s41375-023-01822-2
Publication Date
Columbia Affiliation
View
Xu, J. J., Chalk, A. M., Wall, M., Langdon, W. Y., Smeets, M. F., & Walkley, C. R. (2022). Srsf2P95H/+ co-operates with loss of TET2 to promote myeloid bias and initiate a chronic myelomonocytic leukemia-like disease in mice. Leukemia, 36(12), 2883–2893. https://doi.org/10.1038/s41375-022-01727-6
Publication Date
Columbia Affiliation
Meyer, A. E., Stelloh, C., Pulakanti, K., Burns, R., Fisher, J. B., Heimbruch, K. E., Tarima, S., Furumo, Q., Brennan, J., Zheng, Y., Viny, A. D., Vassiliou, G. S., & Rao, S. (2022). Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;Cohesin mutated AML. Leukemia, 36(8), 2032–2041. https://doi.org/10.1038/s41375-022-01632-y
Publication Date
Columbia Affiliation
Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A. D., Araujo, I. B. de O., Berti, E., Bhagat, G., Borges, A. M., Boyer, D., Calaminici, M., Chadburn, A., Chan, J. K. C., Cheuk, W., Chng, W.-J., Choi, J. K., Chuang, S.-S., Coupland, S. E., Czader, M., Dave, S. S., … Xiao, W. (2022). The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia, 36(7), 1720–1748. https://doi.org/10.1038/s41375-022-01620-2
Publication Date
Columbia Affiliation
View
Komrokji, R. S., Platzbecker, U., Fenaux, P., Zeidan, A. M., Garcia-Manero, G., Mufti, G. J., Santini, V., Díez-Campelo, M., Finelli, C., Jurcic, J. G., Greenberg, P. L., Sekeres, M. A., DeZern, A. E., Savona, M. R., Shetty, J. K., Ito, R., Zhang, G., Ha, X., Backstrom, J. T., & Verma, A. (2022). Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. Leukemia, 36(5), 1432–1435. https://doi.org/10.1038/s41375-022-01521-4
Publication Date
Columbia Affiliation
View
Vilarrasa-Blasi, R., Verdaguer-Dot, N., Belver, L., Soler-Vila, P., Beekman, R., Chapaprieta, V., Kulis, M., Queirós, A. C., Parra, M., Calasanz, M. J., Agirre, X., Prosper, F., Beà, S., Colomer, D., Marti-Renom, M. A., Ferrando, A., Campo, E., & Martin-Subero, J. I. (2021). Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma. Leukemia, 36(2), 583–587. https://doi.org/10.1038/s41375-021-01389-w
Publication Date
Columbia Affiliation
van der Zwet, J. C. G., Buijs-Gladdines, J. G. C. A. M., Cordo', V., Debets, D. O., Smits, W. K., Chen, Z., Dylus, J., Zaman, G. J. R., Altelaar, M., Oshima, K., Bornhauser, B., Bourquin, J. P., Cools, J., Ferrando, A. A., Vormoor, J., Pieters, R., Vormoor, B., & Meijerink, J. P. P. (2021). MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia, 35(12), 3394–3405. https://doi.org/10.1038/s41375-021-01291-5
Publication Date
Columbia Affiliation
View